focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMyhlth Chck Regulatory News (MHC)

Share Price Information for Myhlth Chck (MHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.25
Bid: 9.00
Ask: 9.50
Change: 0.00 (0.00%)
Spread: 0.50 (5.556%)
Open: 9.25
High: 9.25
Low: 9.25
Prev. Close: 9.25
MHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Results & Q3 Trading Update

7 Sep 2021 07:00

RNS Number : 9030K
MyHealthChecked PLC
07 September 2021
 

MyHealthChecked plc

("MyHealthChecked" or "the Company")

 

Notice of Results & Q3 Trading Update

Investor Presentation

 

MyHealthChecked Plc (AIM: MHC), the consumer home-testing healthcare company, will announce its Half-year Report for the six months ended 30 June 2021 and an update on Q3 trading on Wednesday 29 September 2021.

 

A video recording on the Half-year Report and business outlook will be delivered by CEO, Penny McCormick and will be available to view on the Company's website on the day the results are issued: https://investors.myhealthchecked.com/investors/presentations

 

Analyst presentation

An update briefing for equity analysts and an introduction to the Company will take place on Tuesday 12 October 2021 at 12:30pm BST. For further details analysts should contact Walbrook PR.

 

Investor presentation

Penny McCormick, Chief Executive Officer and Gareth Davies, Chief Financial and Operations Officer will provide a live presentation relating to the Half-year Report via the Investor Meet Company platform on Tuesday 12 October 2021 at 4:30pm BST.

 

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9:00am BST the day before the meeting or at any time during the live presentation.

 

Investors can sign up to Investor Meet Company for free and add to meet MYHEALTHCHECKED PLC via:

https://www.investormeetcompany.com/myhealthchecked-plc/register-investor

 

Investors who already follow MyHealthChecked Plc on the Investor Meet Company platform will automatically be invited.

 

 

For further information contact:

 

MyHealthChecked plc

www.myhealthchecked.com

Penny McCormick, Chief Executive Officer

via Walbrook PR

Gareth Davies, Chief Financial and Operations Officer

SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin

Oberon Capital Ltd (Broker)

Tel: +44 (0)203 179 5344

Mike Seabrook

mikeseabrook@oberoninvestments.com

Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com

Paul McManus / Alice Woodings

Mob: +44(0)7980 541 893 / +44 (0)7407 804 654

 

About MyHealthChecked PLC (www.myhealthcheckedplc.com)

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

 

MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests, now in development following the acquisition of The Genome Store in November 2020. The tests will be made available online, and would be viable for over the counter purchase.

 

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORBRGDCLSGDGBL
Date   Source Headline
11th Apr 20227:00 amRNSDirectorate Changes
25th Mar 20227:00 amRNSIssue of Equity
16th Mar 20222:05 pmRNSSecond Price Monitoring Extn
16th Mar 20222:00 pmRNSPrice Monitoring Extension
7th Mar 20222:06 pmRNSSecond Price Monitoring Extn
7th Mar 20222:00 pmRNSPrice Monitoring Extension
3rd Mar 20221:05 pmRNSDirectorate Change
28th Feb 202211:05 amRNSSecond Price Monitoring Extn
28th Feb 202211:00 amRNSPrice Monitoring Extension
2nd Feb 20224:41 pmRNSSecond Price Monitoring Extn
2nd Feb 20224:36 pmRNSPrice Monitoring Extension
24th Jan 20227:00 amRNSTrading Update
5th Jan 20227:00 amRNSPartnership with Lloyds for COVID Antigen testing
13th Dec 20214:40 pmRNSSecond Price Monitoring Extn
13th Dec 20214:35 pmRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSTrading update
7th Dec 20214:41 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20214:41 pmRNSSecond Price Monitoring Extn
1st Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 202111:06 amRNSSecond Price Monitoring Extn
1st Dec 202111:00 amRNSPrice Monitoring Extension
29th Nov 202111:06 amRNSSecond Price Monitoring Extn
29th Nov 202111:01 amRNSPrice Monitoring Extension
26th Nov 202111:05 amRNSSecond Price Monitoring Extn
26th Nov 202111:00 amRNSPrice Monitoring Extension
25th Nov 202111:06 amRNSSecond Price Monitoring Extn
25th Nov 202111:00 amRNSPrice Monitoring Extension
24th Nov 20219:05 amRNSSecond Price Monitoring Extn
24th Nov 20219:00 amRNSPrice Monitoring Extension
24th Nov 20217:00 amRNSLaunch of COVID-19 rapid antigen test service
8th Oct 20214:41 pmRNSSecond Price Monitoring Extn
8th Oct 20214:36 pmRNSPrice Monitoring Extension
1st Oct 20217:00 amRNSBoard Change
29th Sep 20219:05 amRNSSecond Price Monitoring Extn
29th Sep 20219:00 amRNSPrice Monitoring Extension
29th Sep 20217:00 amRNSHalf-year Report
20th Sep 20212:01 pmRNSPrice Monitoring Extension
20th Sep 20217:00 amRNSStatement re. COVID-19 testing
17th Sep 20215:50 pmRNSStatement re. COVID-19 testing
13th Sep 20219:07 amRNSSecond Price Monitoring Extn
13th Sep 20219:03 amRNSPrice Monitoring Extension
7th Sep 20217:00 amRNSNotice of Results & Q3 Trading Update
1st Sep 20217:00 amRNSMedical laboratory accreditation for COVID testing
26th Aug 202111:05 amRNSSecond Price Monitoring Extn
26th Aug 202111:01 amRNSPrice Monitoring Extension
24th Aug 20217:00 amRNSStatement re. DHSC press release
30th Jul 20217:00 amRNSIssue of equity/PDMR Dealing
7th Jul 202111:06 amRNSSecond Price Monitoring Extn
7th Jul 202111:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.